{"id":"https://openalex.org/W7204248761","doi":"https://doi.org/10.2147/ott.s613848","title":"Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy \u2013 An Exploratory Analysis of the INFINITY Precision Oncology Registry","display_name":"Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy \u2013 An Exploratory Analysis of the INFINITY Precision Oncology Registry","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204248761","doi":"https://doi.org/10.2147/ott.s613848","pmid":"https://pubmed.ncbi.nlm.nih.gov/42670512","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13526340"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s613848","doi":"https://doi.org/10.2147/ott.s613848","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s613848","pdf_url":"https://www.dovepress.com/article/download/118787","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/118787","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055006530","display_name":"Karin Potthoff","orcid":"https://orcid.org/0000-0003-1015-9624","observed_orcids":["https://orcid.org/0000-0003-1015-9624"]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Karin Potthoff","raw_affiliation_strings":["Medical Department, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021977358","display_name":"Corinne Vannier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Corinne Vannier","raw_affiliation_strings":["Medical Department, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017172335","display_name":"Uwe M. Martens","orcid":"https://orcid.org/0000-0001-7999-4359","observed_orcids":["https://orcid.org/0000-0001-7999-4359"]},"institutions":[{"id":"https://openalex.org/I4210155170","display_name":"SLK-Kliniken Heilbronn","ror":"https://ror.org/05btveq09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155170"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe M Martens","raw_affiliation_strings":["Department of Internal Medicine III, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany"],"raw_orcid":"https://orcid.org/0000-0001-7999-4359","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany","institution_ids":["https://openalex.org/I4210155170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110447572","display_name":"Matthias S. Matter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matthias Matter","raw_affiliation_strings":["Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070723609","display_name":"Philip M. Jermann","orcid":"https://orcid.org/0000-0002-8836-4946","observed_orcids":["https://orcid.org/0000-0002-8836-4946"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Philip Martin Jermann","raw_affiliation_strings":["Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-8836-4946","affiliations":[{"raw_affiliation_string":"Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034706637","display_name":"Heinz Philipp Laubli","orcid":"https://orcid.org/0000-0002-8910-5620","observed_orcids":["https://orcid.org/0000-0002-8910-5620"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Heinz L\u00e4ubli","raw_affiliation_strings":["Medical Oncology Department, University Hospital Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025656338","display_name":"Ludger Sellmann","orcid":"https://orcid.org/0000-0002-5637-4541","observed_orcids":["https://orcid.org/0000-0002-5637-4541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ludger Sellmann","raw_affiliation_strings":["Oncology Practice, M\u00f6nchengladbach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Practice, M\u00f6nchengladbach, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111328168","display_name":"Jan Schr\u00f6der","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Schr\u00f6der","raw_affiliation_strings":["Medical Care Center for Hematology and Internal Oncology, M\u00fclheim a.d.R., Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Care Center for Hematology and Internal Oncology, M\u00fclheim a.d.R., Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128298810","display_name":"Thomas Decker","orcid":"https://orcid.org/0000-0003-3814-8775","observed_orcids":["https://orcid.org/0000-0003-3814-8775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Decker","raw_affiliation_strings":["Oncology Study Center Ravensburg, Ravensburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Study Center Ravensburg, Ravensburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055479708","display_name":"Markus Kajo Schuler","orcid":"https://orcid.org/0000-0003-0764-1049","observed_orcids":["https://orcid.org/0000-0003-0764-1049"]},"institutions":[{"id":"https://openalex.org/I4210139281","display_name":"Stiftung Oskar Helene Heim","ror":"https://ror.org/052azjr18","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4210139281"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus K Schuler","raw_affiliation_strings":["Medical Care Center Oncology at the Oskar-Helene-Heim, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Care Center Oncology at the Oskar-Helene-Heim, Berlin, Germany","institution_ids":["https://openalex.org/I4210139281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011192527","display_name":"Dominik Marschner","orcid":"https://orcid.org/0009-0003-1639-8762","observed_orcids":["https://orcid.org/0009-0003-1639-8762"]},"institutions":[{"id":"https://openalex.org/I4210161485","display_name":"Klinikum Stuttgart","ror":"https://ror.org/059jfth35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210161485"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Marschner","raw_affiliation_strings":["Department of Hematology, Oncology and Palliative Medicine, Klinikum Stuttgart, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology and Palliative Medicine, Klinikum Stuttgart, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210161485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136627467","display_name":"Matthias Zai\u00df","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthias Zaiss","raw_affiliation_strings":["Practice for Interdisciplinary Oncology and Hematology, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Practice for Interdisciplinary Oncology and Hematology, Freiburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023251571","display_name":"Marcel Reiser","orcid":"https://orcid.org/0000-0002-0457-7793","observed_orcids":["https://orcid.org/0000-0002-0457-7793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcel Reiser","raw_affiliation_strings":["PIOH - Practice for Internal Oncology and Hematology, K\u00f6ln, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PIOH - Practice for Internal Oncology and Hematology, K\u00f6ln, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078686491","display_name":"Michael Neise","orcid":"https://orcid.org/0000-0001-7548-591X","observed_orcids":["https://orcid.org/0000-0001-7548-591X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Neise","raw_affiliation_strings":["Medical Care Center for Hematology and Oncology, Krefeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Care Center for Hematology and Oncology, Krefeld, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012490196","display_name":"Marc\u2010Alexander Rauschendorf","orcid":"https://orcid.org/0000-0003-0940-0521","observed_orcids":["https://orcid.org/0000-0003-0940-0521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc-Alexander Rauschendorf","raw_affiliation_strings":["Medical Affairs, Molecular Health GmbH, Heidelberg, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0940-0521","affiliations":[{"raw_affiliation_string":"Medical Affairs, Molecular Health GmbH, Heidelberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017019037","display_name":"Sina Grebhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sina Grebhardt","raw_affiliation_strings":["Clinical Operations, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036003589","display_name":"Patrick Rudolf Wright","orcid":"https://orcid.org/0000-0002-1153-0846","observed_orcids":["https://orcid.org/0000-0002-1153-0846"]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Patrick R Wright","raw_affiliation_strings":["Biostatistics, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010353950","display_name":"Sandra Maria Woerner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sandra Maria Woerner","raw_affiliation_strings":["Medical Department, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081809269","display_name":"Larissa Elisabeth Hillebrand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Larissa E Hillebrand","raw_affiliation_strings":["Medical Department, iOMEDICO, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017224763","display_name":"Benjamin Kasenda","orcid":"https://orcid.org/0000-0003-0110-8585","observed_orcids":["https://orcid.org/0000-0003-0110-8585"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Benjamin Kasenda","raw_affiliation_strings":["Medical Oncology Department, University Hospital Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-0110-8585","affiliations":[{"raw_affiliation_string":"Medical Oncology Department, University Hospital Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034764832","display_name":"Norbert Walter Marschner","orcid":"https://orcid.org/0000-0002-6098-1301","observed_orcids":["https://orcid.org/0000-0002-6098-1301","https://orcid.org/0009-0001-7065-9690"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]},{"id":"https://openalex.org/I4210137496","display_name":"Iomedico (Germany)","ror":"https://ror.org/03j5af397","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210137496"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Norbert Marschner","raw_affiliation_strings":["Department of Medicine 1, University Medical Center Freiburg, Freiburg, Germany","Medical Department, iOMEDICO, Freiburg, Germany"],"raw_orcid":"https://orcid.org/0009-0001-7065-9690","affiliations":[{"raw_affiliation_string":"Department of Medicine 1, University Medical Center Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]},{"raw_affiliation_string":"Medical Department, iOMEDICO, Freiburg, Germany","institution_ids":["https://openalex.org/I4210137496"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5055006530"],"corresponding_institution_ids":["https://openalex.org/I4210137496"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 19","issue":null,"first_page":"1","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7379999756813049},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8870000243186951},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tumor-genomic-profiles","display_name":"tumor genomic profiles","score":0.8199999928474426},{"id":"https://openalex.org/keywords/keap1-mutation","display_name":"KEAP1 mutation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/clinical-benefit","display_name":"clinical benefit","score":0.7639999985694885},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7710000276565552},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8190000057220459},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6840000152587891},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.632099986076355},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.5722000002861023},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.508899986743927},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5063999891281128},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4821999967098236},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46059998869895935},{"id":"https://openalex.org/C3020497934","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision oncology","level":3,"score":0.4383000135421753},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4307999908924103},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.4187000095844269},{"id":"https://openalex.org/C3018260909","wikidata":"https://www.wikidata.org/wiki/Q1322871","display_name":"Exploratory analysis","level":2,"score":0.3968000113964081},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.37380000948905945},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.36890000104904175},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32359999418258667},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.32350000739097595},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32030001282691956},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2897000014781952},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2892000079154968},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.28760001063346863},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2833999991416931},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.2791999876499176},{"id":"https://openalex.org/C124535831","wikidata":"https://www.wikidata.org/wiki/Q4915074","display_name":"Biomarker discovery","level":4,"score":0.2678000032901764},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.2669999897480011},{"id":"https://openalex.org/C2780416959","wikidata":"https://www.wikidata.org/wiki/Q22907415","display_name":"Companion diagnostic","level":3,"score":0.26570001244544983}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/ott.s613848","doi":"https://doi.org/10.2147/ott.s613848","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s613848","pdf_url":"https://www.dovepress.com/article/download/118787","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13526340","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13526340/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13526340/pdf/OTT-19-613848.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmid:42670512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42670512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/118787","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/tumor-genomic-profiles-associated-with-clinical-benefit-from-immune-ch-peer-reviewed-fulltext-article-OTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:freidok.uni-freiburg.de:286611","doi":null,"is_oa":false,"landing_page_url":"https://nbn-resolving.org/urn:nbn:de:bsz:25-freidok-2866111","pdf_url":null,"source":{"id":"https://openalex.org/S4306401057","display_name":"FreiDok plus (Universit\u00e4tsbibliothek Freiburg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I161046081","host_organization_name":"University of Freiburg","host_organization_lineage":["https://openalex.org/I161046081"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoTargets and therapy. - 19 (2026) , 613848, ISSN: 1178-6930","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/ott.s613848","doi":"https://doi.org/10.2147/ott.s613848","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s613848","pdf_url":"https://www.dovepress.com/article/download/118787","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320313690","display_name":"Novocure","ror":"https://ror.org/018ec2p66"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204248761.pdf","grobid_xml":"https://content.openalex.org/works/W7204248761.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1940241680","https://openalex.org/W2527905628","https://openalex.org/W2606495925","https://openalex.org/W2611933383","https://openalex.org/W2635951006","https://openalex.org/W2747774814","https://openalex.org/W2760942750","https://openalex.org/W2913510976","https://openalex.org/W2924122631","https://openalex.org/W2947227655","https://openalex.org/W2981790403","https://openalex.org/W2990895669","https://openalex.org/W2994573450","https://openalex.org/W3005376436","https://openalex.org/W3043245243","https://openalex.org/W3080758793","https://openalex.org/W3087562474","https://openalex.org/W3111084373","https://openalex.org/W3119518737","https://openalex.org/W3137019085","https://openalex.org/W3163043083","https://openalex.org/W3191302681","https://openalex.org/W3197121316","https://openalex.org/W3203575974","https://openalex.org/W4281920535","https://openalex.org/W4308555508","https://openalex.org/W4380538024","https://openalex.org/W4392186972","https://openalex.org/W4399068373","https://openalex.org/W7124159131"],"related_works":["https://openalex.org/W4306404665","https://openalex.org/W2897815318","https://openalex.org/W4365448704","https://openalex.org/W2905347651","https://openalex.org/W2945998739","https://openalex.org/W4253556790","https://openalex.org/W3017774671","https://openalex.org/W2254576822","https://openalex.org/W4200189218","https://openalex.org/W4229716716"],"abstract_inverted_index":{"Background":[0],"and":[1,12,46,52,88,115,136,167,181,199,214,237,247],"Purpose:":[2],"The":[3],"multicenter":[4],"precision":[5,271],"oncology":[6],"registry":[7,94],"INFINITY":[8,93],"investigated":[9],"biomarker-driven":[10],"therapy":[11,23,192],"outcomes":[13],"in":[14,24,28,196,219,249],"patients":[15,66,163,169,186,220],"with":[16,96,164,187,221],"advanced":[17],"malignancies":[18,45],"not":[19],"eligible":[20],"for":[21,56,142,179],"standard":[22],"routine":[25],"clinical":[26,108,117,165,171,188,222],"care":[27],"Germany.":[29],"Although":[30],"programmed":[31],"cell":[32],"death":[33],"(ligand)":[34],"1":[35],"(PD-(L)1)":[36],"antibodies":[37],"have":[38],"changed":[39],"the":[40,92,128,139,147,161,233,238],"treatment":[41,57],"landscape":[42],"of":[43,208],"several":[44],"PD-(L)1":[47,71],"expression":[48],"level":[49],"is":[50,254],"predictive":[51,60,258],"therefore":[53],"often":[54],"used":[55],"selection,":[58],"existing":[59],"biomarkers":[61],"are":[62,245],"insufficient":[63],"to":[64,77,138,263],"identify":[65,78],"who":[67],"will":[68],"benefit":[69,83,109,118,166,189,223],"from":[70,84,91,127,133,190,224],"inhibitor-based":[72],"therapy.":[73,86],"This":[74],"project":[75],"aimed":[76],"genomic":[79,265],"tumor":[80,175,240],"profiles":[81,176],"predicting":[82],"anti-PD-(L)1":[85,97,191],"Patients":[87,90],"Methods:":[89],"treated":[95],"monotherapy":[98],"were":[99,131,177],"stratified":[100],"into":[101],"two":[102],"cohorts":[103,253],"using":[104,146],"a":[105,206],"case\u2013control":[106],"design:":[107],"(treatment":[110,119],"duration":[111,120],">":[112],"182":[113],"days)":[114],"no":[116],"22\u2013":[121],"63":[122],"days).":[123],"Tumor":[124],"tissue":[125],"samples":[126],"virtual":[129],"biobank":[130],"requested":[132],"local":[134],"pathologies":[135],"sent":[137],"central":[140],"pathology":[141],"next\u2011generation":[143],"sequencing":[144],"(NGS)":[145],"Oncomine":[148],"TM":[149],"Comprehensive":[150],"Assay":[151],"Plus":[152],"panel":[153],"(Thermo":[154],"Fisher,":[155],"NGS":[156],"pan-cancer":[157],"assay).":[158],"Results:":[159],"Of":[160],"26":[162],"24":[168],"without":[170],"benefit,":[172],"NGS-based":[173],"genetic":[174,194],"available":[178],"11":[180],"8":[182],"patients,":[183],"respectively.":[184],"Only":[185],"showed":[193],"alterations":[195],"KEAP1,":[197,212],"PIK3CA":[198,213],"MRE11":[200,215],".":[201],"Conclusion:":[202],"Our":[203],"analysis":[204],"revealed":[205],"set":[207],"three":[209],"genes":[210],"(":[211],")":[216],"exclusively":[217],"mutated":[218],"PD-(L)1-inhibitor":[225],"therapy,":[226],"possibly":[227],"representing":[228],"promising":[229],"biomarker":[230],"candidates.":[231],"Given":[232],"small":[234],"sample":[235],"size":[236],"heterogeneous":[239],"types":[241],"included,":[242],"these":[243,264],"findings":[244],"exploratory,":[246],"validation":[248],"larger,":[250],"preferably":[251],"tumor-type-specific":[252],"required":[255],"before":[256],"any":[257],"value":[259],"can":[260],"be":[261],"attributed":[262],"alterations.":[266],"Keywords:":[267],"registries,":[268],"biomarkers,":[269],"real-world,":[270],"oncology,":[272],"PD-L1":[273]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-27T00:00:00"}